Caspase-3-like proteases and 6-hydroxydopamine induced neuronal cell death

Brain Res Mol Brain Res. 1999 Jan 22;64(1):141-8. doi: 10.1016/s0169-328x(98)00318-0.

Abstract

Neurotoxicity induced by 6-hydroxydopamine (6-OHDA) is believed to be due, in part, to the production of reactive oxygen species (ROS) and/or an inhibition of mitochondrial function. However, little is known about the ensuing intracellular events which ultimately result in cell death. Here we show that exposure to relatively low concentrations of 6-OHDA induces apoptosis of cerebellar granule neurons (CGN). 6-OHDA-induced apoptosis of CGN is associated with activation of a caspase-3-like protease. Western blots of cytosolic extracts from 6-OHDA-treated CGN reveal a translocation of cytochrome c from mitochondria to the cytosol, which precedes activation of the protease detected by Ac-DEVD-pNA. DNA laddering can be blocked by caspase inhibitors zVAD-FMK and Ac-DEVD-CHO, however cell death can only be attenuated for a short time period in the presence of these inhibitors. Our data suggest that 6-OHDA-induced apoptosis of CGN involves activation of a caspase-3-like protease. In contrast to the neurotoxicity induced by MPP+, however, the peptide inhibitors zVAD-FMK and Ac-DEVD-CHO can only attenuate early neuronal death induced by 6-OHDA. At later time points, neuronal death lacking DNA laddering occurs even in the presence of the peptide inhibitor zVAD-FMK or Ac-DEVD-CHO.

MeSH terms

  • 1-Methyl-4-phenylpyridinium / pharmacology
  • Amino Acid Chloromethyl Ketones / pharmacology
  • Animals
  • Apoptosis / drug effects
  • Apoptosis / physiology*
  • Caspase 3
  • Caspases / analysis*
  • Cells, Cultured
  • Cerebellum / cytology
  • Cysteine Proteinase Inhibitors / pharmacology
  • Cytochrome c Group / analysis
  • Cytochrome c Group / metabolism
  • DNA Fragmentation
  • Dopamine Agents / pharmacology
  • Mitochondria / enzymology
  • Neurons / cytology*
  • Neurons / drug effects
  • Neurons / enzymology*
  • Oligopeptides / pharmacology
  • Oxidopamine
  • Parkinson Disease, Secondary / chemically induced
  • Parkinson Disease, Secondary / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Sympatholytics

Substances

  • Amino Acid Chloromethyl Ketones
  • Cysteine Proteinase Inhibitors
  • Cytochrome c Group
  • Dopamine Agents
  • Oligopeptides
  • Sympatholytics
  • acetyl-aspartyl-glutamyl-valyl-aspartal
  • benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone
  • Oxidopamine
  • Casp3 protein, rat
  • Caspase 3
  • Caspases
  • 1-Methyl-4-phenylpyridinium